Join HealthHIV and expert panelists for an interactive live webinar to exchange ideas on opportunities and challenges of implementing pan-viral testing and linkage to care within Emergency Departments and Urgent Care Centers. Emergency medicine physicians, Kimberly Stanford, MD, MPH, Ethan Cowan, MD, MS, and Immediate Past President of the AMA, Jesse Ehrenfeld, MD, MPH, FAMIA, FASA, will discuss the need for pan-viral (HIV, HBV, HCV, and STIs) testing and linkage to care in EDs and UCCs, and share evidence-based standards of care for pan-viral testing.
Over the course of this 1.5 credits/contact hours certified activity, key topics will include:
- Importance of EDs and urgent care as community touch points for pan-viral testing (e.g. meeting impacted populations where they are)
- Understanding prevalence of HIV, HBV, HCV, and STIs in your community
- Evidence-based care guidance and recommendations for HIV, HBV, HCV, and STIs
- Implementation of testing algorithms and test interpretation
- Effective strategies for patient follow-up and linkage to care/treatment
This webinar will include participant polling, live Q&A, and links to additional resources, as well as more information about how you may be able to participate in individualized capacity building and coaching support from HealthHIV to implement pan-viral testing and linkage to care. This is the second of a three-part webinar series that will provide critical information and guidance and implementation models for pan-viral testing and linkage to care in student health centers, emergency departments, and urgent care settings.
Faculty
Kimberly Stanford, MD, MPH
Associate Professor of Medicine
The University of Chicago Medicine
Chicago, IL
Ethan Cowan, MD, MS
Professor of Emergency Medicine
Rutgers New Jersey Medical School
Newark, NJ
Jesse Ehrenfeld, MD, MPH, FAMIA, FASA
Senior Associate Dean and Professor of Anesthesiology
Medical College of Wisconsin
Milwaukee, WI
Educational Objectives
After completing this activity, the participant should be better able to:
- Implement national guidelines and recommendations for pan-viral (HIV, HBV, HCV, and STIs) testing and linkage to care.
- Identify innovative pan-viral testing technologies, models and resources, such as self-/at-home testing.
- Identify pan-viral linkage to care models to connect patients to care.
- Apply testing strategies that enhance health equity for populations disproportionately impacted by HIV, HBV, HCV, and STIs.
Target Audience
Primary care providers, pharmacists, nurses, nurse practitioners, physician associates, social workers, and other healthcare professionals in involved in the testing, identification and linkage to care for individuals with HIV, HBV, HCV, and STIs at student health centers, emergency departments, urgent care clinics, and other non-traditional settings.
Jointly Provided by:
Accreditation, Support, and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
ECMEC® Credit
The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)™ into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).
PA
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.50 contact hour.
Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this application-based continuing education activity for 1.50 contact hour (0.15 CEU) of the Accreditation Council for Pharmacy Education.
UAN: JA0007322-9999-25-012-L01-P
Social Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.50 clinical social work continuing education credit.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Disclosure and Conflict of Interest Policy
Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
- Kimberly Stanford, MD, MPH
Kimberly Stanford, MD, MPH, has no relevant financial relationships with ineligible companies to disclose for this educational activity. - Ethan Cowan, MD, MS
Ethan Cowan, MD, MS, has a financial interest/relationship or affiliation in the form of:- Consultant/Advisor: Indivior, LLC (ended 02/15/2024)
- Research Funding: Gilead Sciences (ended 01/14/2024)
- Other: Premier Research, DSMB
- Jesse E. Ehrenfeld, MD, MPH, FAMIA, FASA
Jesse E. Ehrenfeld, MD, MPH, FAMIA, FASA, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviews
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity, however registration is required. In order to receive credit, learners must participate in the entire CE activity. A statement of credit will be issued only upon receipt of a completed activity evaluation and will be emailed to you upon completion. You will receive your certificate from HealthHIV. If you have questions regarding your certificate, please contact Shannon Morgan via email at [email protected].
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About this Activity
Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
